vs

Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and MYRIAD GENETICS INC (MYGN). Click either name above to swap in a different company.

MYRIAD GENETICS INC is the larger business by last-quarter revenue ($209.8M vs $173.1M, roughly 1.2× PATHWARD FINANCIAL, INC.). On growth, PATHWARD FINANCIAL, INC. posted the faster year-over-year revenue change (-0.2% vs -0.4%). Over the past eight quarters, MYRIAD GENETICS INC's revenue compounded faster (1.9% CAGR vs -18.0%).

Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.

Myriad Genetics, Inc. is an American genetic testing and precision medicine company based in Salt Lake City, Utah, United States. Myriad employs a number of proprietary technologies that permit doctors and patients to understand the genetic basis of human disease and the role that genes play in the onset, progression and treatment of disease. This information is used to guide the development of new products that assess an individual's risk for developing disease later in life, identify a pati...

CASH vs MYGN — Head-to-Head

Bigger by revenue
MYGN
MYGN
1.2× larger
MYGN
$209.8M
$173.1M
CASH
Growing faster (revenue YoY)
CASH
CASH
+0.1% gap
CASH
-0.2%
-0.4%
MYGN
Faster 2-yr revenue CAGR
MYGN
MYGN
Annualised
MYGN
1.9%
-18.0%
CASH

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CASH
CASH
MYGN
MYGN
Revenue
$173.1M
$209.8M
Net Profit
$35.2M
Gross Margin
70.0%
Operating Margin
24.6%
-2.7%
Net Margin
20.3%
Revenue YoY
-0.2%
-0.4%
Net Profit YoY
11.9%
EPS (diluted)
$1.57
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CASH
CASH
MYGN
MYGN
Q4 25
$173.1M
$209.8M
Q3 25
$186.7M
$205.7M
Q2 25
$195.8M
$213.1M
Q1 25
$274.8M
$195.9M
Q4 24
$182.6M
$210.6M
Q3 24
$179.5M
$213.3M
Q2 24
$188.6M
$211.5M
Q1 24
$257.6M
$202.2M
Net Profit
CASH
CASH
MYGN
MYGN
Q4 25
$35.2M
Q3 25
$38.8M
$-27.4M
Q2 25
$42.1M
$-330.5M
Q1 25
$75.0M
$-100.0K
Q4 24
$30.0M
Q3 24
$33.5M
$-22.1M
Q2 24
$44.9M
$-36.7M
Q1 24
$69.9M
$-26.0M
Gross Margin
CASH
CASH
MYGN
MYGN
Q4 25
70.0%
Q3 25
69.9%
Q2 25
71.2%
Q1 25
68.5%
Q4 24
71.7%
Q3 24
70.2%
Q2 24
69.6%
Q1 24
68.1%
Operating Margin
CASH
CASH
MYGN
MYGN
Q4 25
24.6%
-2.7%
Q3 25
25.9%
-11.3%
Q2 25
24.1%
-154.5%
Q1 25
33.2%
-14.8%
Q4 24
19.8%
-18.6%
Q3 24
20.9%
-9.4%
Q2 24
27.1%
-17.3%
Q1 24
33.8%
-13.8%
Net Margin
CASH
CASH
MYGN
MYGN
Q4 25
20.3%
Q3 25
20.8%
-13.3%
Q2 25
21.5%
-155.1%
Q1 25
27.3%
-0.1%
Q4 24
16.4%
Q3 24
18.7%
-10.4%
Q2 24
23.8%
-17.4%
Q1 24
27.1%
-12.9%
EPS (diluted)
CASH
CASH
MYGN
MYGN
Q4 25
$1.57
$-0.09
Q3 25
$1.69
$-0.29
Q2 25
$1.81
$-3.57
Q1 25
$3.14
$0.00
Q4 24
$1.23
$-0.47
Q3 24
$1.34
$-0.24
Q2 24
$1.78
$-0.41
Q1 24
$2.74
$-0.29

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CASH
CASH
MYGN
MYGN
Cash + ST InvestmentsLiquidity on hand
$331.2M
$149.6M
Total DebtLower is stronger
$33.5M
$119.9M
Stockholders' EquityBook value
$854.5M
$368.0M
Total Assets
$7.6B
$706.6M
Debt / EquityLower = less leverage
0.04×
0.33×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CASH
CASH
MYGN
MYGN
Q4 25
$331.2M
$149.6M
Q3 25
$120.6M
$145.4M
Q2 25
$258.3M
$74.4M
Q1 25
$254.2M
$91.8M
Q4 24
$597.4M
$102.4M
Q3 24
$158.3M
$99.9M
Q2 24
$298.9M
$97.3M
Q1 24
$347.9M
$104.3M
Total Debt
CASH
CASH
MYGN
MYGN
Q4 25
$33.5M
$119.9M
Q3 25
$33.5M
$119.5M
Q2 25
$33.4M
Q1 25
$33.4M
Q4 24
$33.4M
Q3 24
$33.4M
Q2 24
$33.3M
Q1 24
$33.4M
Stockholders' Equity
CASH
CASH
MYGN
MYGN
Q4 25
$854.5M
$368.0M
Q3 25
$858.0M
$372.8M
Q2 25
$819.0M
$388.1M
Q1 25
$814.7M
$704.9M
Q4 24
$758.3M
$701.1M
Q3 24
$822.5M
$731.7M
Q2 24
$748.4M
$740.5M
Q1 24
$719.5M
$760.0M
Total Assets
CASH
CASH
MYGN
MYGN
Q4 25
$7.6B
$706.6M
Q3 25
$7.2B
$728.1M
Q2 25
$7.2B
$677.3M
Q1 25
$7.0B
$1.0B
Q4 24
$7.6B
$1.0B
Q3 24
$7.5B
$1.1B
Q2 24
$7.5B
$1.1B
Q1 24
$7.4B
$1.1B
Debt / Equity
CASH
CASH
MYGN
MYGN
Q4 25
0.04×
0.33×
Q3 25
0.04×
0.32×
Q2 25
0.04×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.04×
Q2 24
0.04×
Q1 24
0.05×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CASH
CASH
MYGN
MYGN
Operating Cash FlowLast quarter
$108.3M
$10.6M
Free Cash FlowOCF − Capex
$104.1M
FCF MarginFCF / Revenue
60.1%
Capex IntensityCapex / Revenue
2.4%
Cash ConversionOCF / Net Profit
3.08×
TTM Free Cash FlowTrailing 4 quarters
$616.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CASH
CASH
MYGN
MYGN
Q4 25
$108.3M
$10.6M
Q3 25
$303.7M
$21.1M
Q2 25
$30.4M
$-13.6M
Q1 25
$188.3M
$-16.3M
Q4 24
$-71.7M
$6.6M
Q3 24
$143.1M
$700.0K
Q2 24
$113.2M
$2.6M
Q1 24
$203.0M
$-18.6M
Free Cash Flow
CASH
CASH
MYGN
MYGN
Q4 25
$104.1M
Q3 25
$300.3M
Q2 25
$27.7M
Q1 25
$184.7M
Q4 24
$-73.8M
Q3 24
$138.8M
Q2 24
$111.0M
Q1 24
$201.3M
FCF Margin
CASH
CASH
MYGN
MYGN
Q4 25
60.1%
Q3 25
160.9%
Q2 25
14.1%
Q1 25
67.2%
Q4 24
-40.4%
Q3 24
77.3%
Q2 24
58.8%
Q1 24
78.1%
Capex Intensity
CASH
CASH
MYGN
MYGN
Q4 25
2.4%
Q3 25
1.8%
Q2 25
1.4%
Q1 25
1.3%
Q4 24
1.1%
Q3 24
2.4%
Q2 24
1.2%
Q1 24
0.7%
Cash Conversion
CASH
CASH
MYGN
MYGN
Q4 25
3.08×
Q3 25
7.83×
Q2 25
0.72×
Q1 25
2.51×
Q4 24
-2.39×
Q3 24
4.27×
Q2 24
2.52×
Q1 24
2.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CASH
CASH

Consumer$103.0M59%
Payment Card And Deposit Fees$30.1M17%
Other$24.2M14%
Rental Income$11.6M7%
Commercial$4.2M2%

MYGN
MYGN

Segment breakdown not available.

Related Comparisons